Literature DB >> 15158142

Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors.

Larissa Fabritz1, Paulus Kirchhof, Lisa Fortmüller, John A Auchampach, Hideo A Baba, Günter Breithardt, Joachim Neumann, Peter Boknik, Wilhelm Schmitz.   

Abstract

OBJECTIVE: An increased expression of adenosine receptors is a promising target for gene therapy aimed at protecting the myocardium against ischemic damage, but may alter cardiac electrophysiology. We therefore studied the effects of heart-directed overexpression of A(3) adenosine receptors (A(3)ARs) at different gene doses on sinus and atrio-ventricular (AV) nodal function in mice. METHODS AND
RESULTS: Mice with heart-specific overexpression of A(3)AR at high (A(3)(high)) or low (A(3)(low)) levels and their wild-type littermates were studied. Telemetric electrocardiogram (ECG) recordings in adult freely moving A(3)(high) mice showed profound sinus bradycardia resulting in either ventricular escape rhythms or an incessant bradycardia-tachycardia syndrome (minimal heart rate A(3)(high) 217+/-25*; WT 406+/-21 beats/min, all values as mean+/-S.E.M., n=7 per genotype, *p<0.05). Exercise attenuated bradycardia in A(3)(high) mice (maximal heart rate A(3)(high) 650+/-13*; WT 796+/-13 beats/min) and first-degree AV nodal block was present (PQ interval A(3)(high) 36+/-4*; WT 23+/-5 ms). Isolated hearts showed complete heart block (10/17 A(3)(high)* vs. 1/17 WT). Atrial bradycardia and AV block were already present 3 weeks after birth. Doppler echocardiography revealed atrial dysfunction and progressive atrial enlargement that was moderate at 3 and 8 weeks, and progressed at 12 and 21 weeks of age (all p<0.05 vs. WT). Atrial contractility and sarcoendoplasmic Ca(2+) ATPase (SERCA) 2a protein expression were reduced in isolated left A(3)(high) atria at the age of 14 weeks. Fibrosis was present in left A(3)(high) atria at 14 weeks, but not at 5 weeks of age. A(3)(low) mice had first-degree AV block without arrhythmias or structural changes.
CONCLUSIONS: Heart-directed overexpression of A(3)AR resulted in gene dose-dependent AV block and pronounced sinus nodal dysfunction in vivo. Profound bradycardia heralded atrial and ventricular dilatation, dysfunction, and fibrosis. In contrast to A(1) adenosine receptors (A(1)AR), the effects of A(3)AR overexpression were attenuated during exercise. This may have implications for the physiology of sinus nodal regulation and for therapeutic attempts to increase the expression of adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158142      PMCID: PMC3910327          DOI: 10.1016/j.cardiores.2004.02.004

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  33 in total

1.  A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca(2+) release in rat heart.

Authors:  R Zucchi; G Yu; S Ghelardoni; F Ronca; S Ronca-Testoni
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

Review 2.  The onset and autonomic regulation of cardiac pacemaker activity: relevance of the f current.

Authors:  D DiFrancesco
Journal:  Cardiovasc Res       Date:  1995-04       Impact factor: 10.787

3.  Molecular mechanism of cAMP modulation of HCN pacemaker channels.

Authors:  B J Wainger; M DeGennaro; B Santoro; S A Siegelbaum; G R Tibbs
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

4.  A partial agonist of the A(1)-adenosine receptor selectively slows AV conduction in guinea pig hearts.

Authors:  L Wu; L Belardinelli; J A Zablocki; V Palle; J C Shryock
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

5.  Selective attenuation of isoproterenol-stimulated arrhythmic activity by a partial agonist of adenosine A1 receptor.

Authors:  Yejia Song; Lin Wu; John C Shryock; Luiz Belardinelli
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

6.  Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

Authors:  J J Hunter; N Tanaka; H A Rockman; J Ross; K R Chien
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

Review 7.  Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes.

Authors:  L Belardinelli; J C Shryock; Y Song; D Wang; M Srinivas
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

8.  Predisposition to arrhythmia and autonomic dysfunction in Nhlh1-deficient mice.

Authors:  Tiziana Cogliati; Deborah J Good; Mark Haigney; Petra Delgado-Romero; Michael A Eckhaus; Walter J Koch; Ilan R Kirsch
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor.

Authors:  T M Palmer; T W Gettys; G L Stiles
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

10.  Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism.

Authors:  T M Palmer; J L Benovic; G L Stiles
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  24 in total

Review 1.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

3.  RNAseq shows an all-pervasive day-night rhythm in the transcriptome of the pacemaker of the heart.

Authors:  Yanwen Wang; Cali Anderson; Halina Dobrzynski; George Hart; Alicia D'Souza; Mark R Boyett
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

4.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

5.  ZO-1 Regulates Intercalated Disc Composition and Atrioventricular Node Conduction.

Authors:  Le Shen; Christopher R Weber; Wenli Dai; Rangarajan D Nadadur; Jaclyn A Brennan; Heather L Smith; Kaitlyn M Shen; Margaret Gadek; Brigitte Laforest; Mingyi Wang; Joanna Gemel; Ye Li; Jing Zhang; Bruce D Ziman; Jiajie Yan; Xun Ai; Eric C Beyer; Edward G Lakata; Narayanan Kasthuri; Igor R Efimov; Michael T Broman; Ivan P Moskowitz
Journal:  Circ Res       Date:  2020-04-29       Impact factor: 17.367

Review 6.  Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man.

Authors:  Arthur M Feldman; Ellina Cheksis-Feiner; Eman Hamad; Tung Chan
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

7.  Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury.

Authors:  Vladimir Shneyvays; Dorit Leshem; Tova Zinman; Liaman K Mamedova; Kenneth A Jacobson; Asher Shainberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-28       Impact factor: 4.733

8.  Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.

Authors:  Larissa Fabritz; Dierk Damke; Markus Emmerich; Susann G Kaufmann; Kathrin Theis; Andreas Blana; Lisa Fortmüller; Sandra Laakmann; Sven Hermann; Elena Aleynichenko; Johannes Steinfurt; Daniela Volkery; Burkhard Riemann; Uwe Kirchhefer; Michael R Franz; Günter Breithardt; Edward Carmeliet; Michael Schäfers; Sebastian K G Maier; Peter Carmeliet; Paulus Kirchhof
Journal:  Cardiovasc Res       Date:  2010-01-28       Impact factor: 10.787

9.  Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP.

Authors:  Dagmar Harzheim; K Holger Pfeiffer; Larissa Fabritz; Elisabeth Kremmer; Thorsten Buch; Ari Waisman; Paulus Kirchhof; U Benjamin Kaupp; Reinhard Seifert
Journal:  EMBO J       Date:  2008-01-24       Impact factor: 11.598

Review 10.  Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential.

Authors:  Venkataraman Rajaram; Jacob Joseph
Journal:  Curr Heart Fail Rep       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.